METACARE Co., Ltd.
Financials
Valuation Metrics
METACARE Co., Ltd.'s Market Cap is ₩212B. At end of 2025 it was ₩673B. Ranked #2213 of 2,410 in KR market (top 92%), #761 of 779 on KOSPI (top 98%), #90 of 94 in Health Care Equipment & Services (top 96%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 21.17B KRW | KR#2,213/2,410 Sec#90/94 |
| Revenue | 39.95B KRW | KR#1,906/2,410 Sec#55/94 |
| Net Income | -1.84B KRW | KR—/2,410 Sec—/94 |
| Total Assets | 243.95B KRW | KR#1,156/2,410 Sec#28/94 |
| Net Assets | 137.68B KRW | KR#1,193/2,410 Sec#33/94 |
| Employees | 21 | KR#2,237/2,410 Sec#88/94 |
| Value | ||
| P/B | 0.15x | KR#90/2,410 Sec#1/94 |
| P/S | 0.53x | KR#1,050/2,410 Sec#13/94 |
| EV/EBITDA | 60.83x | KR#1,412/2,410 Sec#45/94 |
| FCF Yield | -1.16% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | -1.34% | KR#1,647/2,410 Sec#55/94 |
| ROA | -0.75% | KR#1,642/2,410 Sec#56/94 |
| Op. Margin | 3.38% | KR#1,185/2,410 Sec#44/94 |
| Revenue Growth | 79.86% | KR#118/2,410 Sec#9/94 |
| Financial Health | ||
| Debt Ratio | 77.19% | KR#1,306/2,410 Sec#73/94 |
| Total Debt | 71.84B KRW | KR#852/2,410 Sec#19/94 |
| FCF | -245.3M KRW | KR#1,233/2,410 Sec#35/94 |
| Cash | 10.97B KRW | KR#1,640/2,410 Sec#52/94 |
| Current Ratio | 0.48x | KR#2,145/2,410 Sec#89/94 |
| Net Debt/EBITDA | 45.13x | KR#1,476/2,410 Sec#48/94 |
| Performance | ||
| 1Y Return | -70.37% | KR#2,277/2,410 Sec#91/94 |
| 1M Return | -20.99% | KR#1,764/2,410 Sec#75/94 |
| From 52W High | -74.60% | KR#2,144/2,410 Sec#85/94 |
| 1Y MDD | -73.41% | KR#2,043/2,410 Sec#76/94 |
| Trading | ||
| Volume | 46,774 shares | KR#281/2,410 Sec#9/94 |
| Trading Value | 45.2M KRW | KR#1,045/2,410 Sec#39/94 |
| Foreign Own. | 0.68% | KR#2,140/2,410 Sec#81/94 |
| Per Share | ||
| EPS | -83 KRW | KR—/2,410 Sec—/94 |
| BPS | 6,242 KRW | KR#1,346/2,410 Sec#32/94 |
Company Info
This company was established in 2009, spun off from Woori Pharmacy's Medical Business Division. In 2024, it expanded its real estate business by acquiring Metaprime and added medical service consulting through the acquisition of Momo Labs. Meta Care provides services including the distribution of pharmaceuticals and medical devices, rental and management of non-residential buildings, and management consulting for hair transplant specialty hospitals. It is expanding its healthcare infrastructure through urban leasing projects and pursuing co-growth through partnerships with hair transplant hospitals. Meta Care was founded in 2009 and is headquartered in Hwaseong-si, Gyeonggi-do.